Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Taking Special Care of Dangerous Pathogens with Tecan’s Infinite® 200 PRO

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Tecan’s Infinite® 200 PRO is a simple to use, convenient size and a robust device.

The P4 Inserm-Jean Mérieux laboratory in Lyon is Europe’s largest high security pathogen laboratory, and relies on the flexibility, robustness and reliability of Tecan’s Infinite® 200 PRO monochromator-based microplate reader for use with Risk Group 4 pathogens including the Ebola, Marburg, Lassa, Nipah and Hendra viruses.

Stéphane Mely, Biological Technics Engineer in the in vitro experimentation and diagnostic team at P4, explained: “We chose the Infinite 200 PRO specifically for absorbance-, luminescence- and fluorescence-based assays performed in accordance with very special BSL4 conditions. These include ELISAs, bioluminescence detection using luciferase activity, and pathogen detection with molecules coupled with fluorophores.”

“One of the most important aspects of equipment in a Category 4 laboratory is robustness, not least because of limited access to the laboratory for maintenance and repairs. The Infinite 200 PRO’s resistance to decontamination products such as hydrogen peroxide is essential for our work, and its monochromator system allows us to work with any wavelength we need, without considering whether or not we have the correct filters. It is simple to use, a convenient size and, like all Tecan instruments, is known to be a robust device.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tecan and TAP Biosystems Announces a Co-Marketing Agreement
Companies to automate RAFT™ 3D cell culturing on the Freedom EVO®.
Thursday, November 01, 2012
Tecan Award 2011 Winner Announced
Svenja Kristina Holle from UHM has won 2011 award.
Friday, February 24, 2012
Tecan and Artel Partner to Offer QC Kit
QC Kit - a fully integrated performance verification solution for Freedom EVO® workstations.
Tuesday, February 07, 2012
Tecan Launches new Services for Australasia
New business venture aimed at providing regional support to Tecan customers throughout in Australia, New Zealand and the Pacific islands.
Friday, March 12, 2010
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos